New: ImmuView® Reader 2.0 Enhances C. difficile Testing Workflow
Una Health is pleased to announce the availability of the ImmuView® Reader 2.0, bringing automated result interpretation to the trusted C. DIFF QUIK CHEK COMPLETE® assay.
Laboratories already using the C. DIFF QUIK CHEK COMPLETE assay can now benefit from objective, automated reading without changing their existing test kits or workflow. Simply load the completed test into the reader, press a button, and the ImmuView Reader 2.0 automatically interprets both the antigen and toxin lines, delivering consistent, reliable results every time.
By removing the subjectivity associated with manual visual interpretation, the reader helps standardise result reporting while supporting busy laboratory teams with a faster, more streamlined workflow.
How does it help?
- Objective interpretation – Automated result reading eliminates subjective visual interpretation.
- LIS/LIMS connectivity – Ethernet connectivity enables automatic transfer of results for accurate and efficient reporting.
- Enhanced traceability – Stores up to 999 test results for easy retrieval and audit purposes.
- Simple operation – A glove-compatible 3.4″ colour touchscreen and intuitive place-in, press-test workflow make operation straightforward.
- Plug-and-play integration – Supports USB-connected barcode scanners and printers.
- Compact design – Measuring just 124 × 118 × 142 mm, the reader fits easily onto almost any laboratory bench.
The ImmuView Reader 2.0 has been designed to complement your existing C. DIFF QUIK CHEK COMPLETE testing process, allowing laboratories to improve consistency and traceability without introducing additional complexity.
More to come…
The platform has been designed with future expansion in mind, with extended compatibility for the ImmuView® urinary antigen test portfolio coming soon (ImmuView S. pneumoniae and L. pneumophila), further enhancing its diagnostic versatility. This forthcoming capability will enable laboratories to benefit from the same objective result interpretation, digital connectivity and enhanced traceability across additional rapid diagnostic assays, supporting standardised and efficient testing workflows.
